Meropenem alone and in combination with vancomycin in experimental meningitis caused by a penicillin-resistant pneumococcal strain

Eur J Clin Microbiol Infect Dis. 1999 Dec;18(12):866-70. doi: 10.1007/s100960050421.

Abstract

In a rabbit model of meningitis caused by a pneumococcus highly resistant to penicillin (MIC, 4 microg/ml), meropenem, a broad-spectrum carbapenem, was bactericidal (-0.48+/-0.14 deltalog10 cfu/ml h) and slightly superior to ceftriaxone (-0.34+/-0.23 deltalog10 cfu/ml x h) and vancomycin (-0.39+/-0.19 deltalog10 cfu/ml x h). Although the combination of vancomycin with ceftriaxone was significantly more active than ceftriaxone alone (-0.55+/-0.19 deltalog10 cfu/ml x h), only an insignificant gain was observed by the addition of vancomycin to meropenem (-0.55+/-0.28 deltalog10 cfu/ml x h).

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Ceftriaxone / cerebrospinal fluid
  • Ceftriaxone / pharmacology
  • Ceftriaxone / therapeutic use
  • Cephalosporins / cerebrospinal fluid
  • Cephalosporins / pharmacology
  • Cephalosporins / therapeutic use
  • Colony Count, Microbial
  • Disease Models, Animal
  • Drug Therapy, Combination / cerebrospinal fluid
  • Drug Therapy, Combination / pharmacology
  • Drug Therapy, Combination / therapeutic use*
  • Meningitis, Pneumococcal / drug therapy*
  • Meningitis, Pneumococcal / microbiology
  • Meropenem
  • Microbial Sensitivity Tests
  • Penicillin Resistance
  • Rabbits
  • Streptococcus pneumoniae / drug effects*
  • Thienamycins / cerebrospinal fluid
  • Thienamycins / pharmacology
  • Thienamycins / therapeutic use*
  • Vancomycin / cerebrospinal fluid
  • Vancomycin / pharmacology
  • Vancomycin / therapeutic use*

Substances

  • Cephalosporins
  • Thienamycins
  • Vancomycin
  • Ceftriaxone
  • Meropenem